Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Arbutus Biopharma Corp (I9DN)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
2.558 -0.128    -4.77%
02:02:17 - Delayed Data. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  CA03879J1003 
S/N:  A14XMD
  • Volume: 0
  • Bid/Ask: 2.562 / 2.676
  • Day's Range: 2.558 - 2.558
Arbutus Biopharma 2.558 -0.128 -4.77%

I9DN Balance Sheet

 
Featured here, the Balance Sheet for Arbutus Biopharma Corp, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Collapse All
Period Ending: 2023
31/12
 2023
30/09
 2023
30/06
 2023
31/03
Total Current Assets 132.03 141.61 158.8 152.85
Cash and Short Term Investments 126 134.18 152.48 146.73
Cash - - - -
Cash & Equivalents 26.28 17.53 27.2 40.57
Short Term Investments 99.72 116.65 125.29 106.15
Total Receivables, Net 6.02 2.17 2.61 3.26
Accounts Receivables - Trade, Net 6.02 2.17 2.61 2.66
Total Inventory - - - -
Prepaid Expenses - 5.26 3.7 2.86
Other Current Assets, Total - - - -
Total Assets 144.4 158.64 176.82 191.22
Property/Plant/Equipment, Total - Net 6.09 6.54 6.96 6.52
Property/Plant/Equipment, Total - Gross - 18.08 18.43 17.65
Accumulated Depreciation, Total - -11.54 -11.48 -11.14
Goodwill, Net - - - -
Intangibles, Net - - - -
Long Term Investments 6.28 10.5 11.06 31.79
Note Receivable - Long Term - - - 0.6
Other Long Term Assets, Total - 0.003 0.011 0.062
Other Assets, Total 93.69 114.48 122.67 102.89
Total Current Liabilities 22.49 22.32 24.53 25.15
Accounts Payable 10.27 2.26 1.04 2.46
Payable/Accrued - - - -
Accrued Expenses - 7.55 7.76 7.2
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 0.425 0.412 0.397 0.446
Other Current liabilities, Total 11.79 12.11 15.33 15.06
Total Liabilities 38.38 39.3 42.13 47.31
Total Long Term Debt 6.95 8.11 8.79 9.38
Long Term Debt 6.95 8.11 8.79 9.38
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total 8.94 8.87 8.81 12.77
Total Equity 106.02 119.34 134.69 143.92
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 106.02 1346.02 1344.2 1339.45
Additional Paid-In Capital - 79.55 77.2 74.24
Retained Earnings (Accumulated Deficit) - -1257.34 -1237.24 -1220.14
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total - -48.88 -49.47 -49.63
Total Liabilities & Shareholders' Equity 144.4 158.64 176.82 191.22
Total Common Shares Outstanding 169.9 167.7 166.92 165.13
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

ABUS Comments

Write your thoughts about Arbutus Biopharma Corp
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Superior Lau
Superior Lau Jun 03, 2022 4:41AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
today we slowly up to the moon
Reply
0 0
Report
Edwin Henriquez
Edwin Henriquez Dec 07, 2021 9:46AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
today we go to the moon
Reply
3 1
Report
Michal Nowosielski
Michal Nowosielski Dec 07, 2021 9:46AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
?
Reply
0 0
Report
Sean Duffy
Sean Duffy Dec 03, 2021 12:19PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
when will this stock turn around? anyone know why it is dropping?
Reply
0 0
Report
Zarqawi tube
Zarqawi tube Dec 03, 2021 12:19PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
due to gravity.....
Reply
0 0
Report
Edwin Henriquez
Edwin Henriquez Dec 02, 2021 1:40PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
this is pure manipulation how you know easy think about this Moderna is down almost 10% today on this news since yesterday is going down basically because ABUS will get royalties on their pattern and this happens the winner of the history also down 10% unbelievable
Reply
1 1
Report
Edwin Henriquez
Edwin Henriquez Dec 02, 2021 10:28AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
yeah Aket I think we went to the SUN instead of Mars crazy 🤪 drop like always hedges playing with the market they building PUTs and collecting
Reply
0 0
Report
Aket Orem
Aket Orem Dec 02, 2021 10:28AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Thank to them i bought more 🥴🤌🏾
Reply
0 0
Report
Edwin Henriquez
Edwin Henriquez Dec 02, 2021 10:28AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
wow nice I just double my position on this another 10k lets see at least volume still increasing and thats good 👍
Reply
0 0
Report
Aket Orem
Aket Orem Dec 02, 2021 5:20AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
We go to Mars 🚀🚀🚀
Reply
0 1
Report
Danel Trade
Danel Trade Dec 02, 2021 5:20AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I believe so, we had buyers yesterday all the way to 6-6.50 so it has plenty of room to the upside.
Reply
0 0
Report
Aket Orem
Aket Orem Dec 02, 2021 5:20AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
If ABUS don’t make a annonce about sueing MNR, it’s probably means that they are talking each other for a deal
Reply
0 0
Report
Danel Trade
Danel Trade Dec 02, 2021 5:02AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
interesting reading also here: https://www.tipranks.com/news/blurbs/jmp-securities-believes-arbutus-biopharma-abus-wont-stop-here?mod=mw_quote_news
Reply
1 0
Report
Danel Trade
Danel Trade Dec 02, 2021 4:52AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I hear it is 10% Moderna has to pay to ABUS. Give or take, but it is a looooot of money
Reply
0 0
Report
Aket Orem
Aket Orem Dec 02, 2021 4:52AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Where did you hear that ?
Reply
0 0
Report
Danel Trade
Danel Trade Dec 02, 2021 4:52AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Cant name the sources. As I said give or take. The roumer is around
Reply
1 0
Report
Danel Trade
Danel Trade Dec 02, 2021 2:46AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
make target lies on 20-23
Reply
0 0
Report
Edwin Henriquez
Edwin Henriquez Dec 01, 2021 6:55PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
we should be reaching 8s tomorrow with this much volume plus even though the market over reacting to the new Omicron bsh this could easily be in the 20s by next week ofcourse when rumors comes out of an agreement between Moderna and ABUS this will fly on my calculations Moderna made on this pattern about 72 billions so what ever % they could settle will send this to the moon
Reply
2 1
Report
Aket Orem
Aket Orem Dec 01, 2021 6:55PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
We will buy more 🤌🏾
Reply
0 0
Report
Gabi Rodz
Gabi Rodz Dec 01, 2021 6:55PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Estas seguro de que saldrá de los $4.30?
Reply
0 1
Report
Danel Trade
Danel Trade Dec 01, 2021 6:55PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
One thing is clear, they will make tons of moooonneeeyyy and Modern will have to settle for ***billions
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email